New ankle implant tracked for 5 years to see if it holds up

NCT ID NCT04944576

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study follows about 80 adults who receive the EasyMove total ankle prosthesis for severe ankle arthritis caused by injury, wear-and-tear, or rheumatoid arthritis. Researchers will monitor how often the implant loosens and needs revision, as well as pain, mobility, and function over five years. The goal is to see how well the device performs in everyday medical practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
EasyMove total ankle prosthesis
What this could lead to
If successful, this study could confirm that the EasyMove ankle replacement is safe and works well over the long term for people with severe ankle arthritis.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Long-term complications like implant loosening or infection remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKLE INJURIES AND DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Raymond-Poincaré

    Garches, 92380, France

  • Centre Hospitalier Départemental Vendée

    La Roche-sur-Yon, 85925, France

  • Centre hospitalier universitaire vaudois

    Lausanne, CH-1011, Switzerland

  • Chu Brest

    Brest, 29609, France

  • Clinique Jouvenet

    Paris, 75016, France

  • Clinique Victor HUGO

    Paris, 75008, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.